These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23614479)

  • 1. Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).
    Hudgens S; Breeze J; Spalding J
    J Med Econ; 2013; 16(6):828-34. PubMed ID: 23614479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Patient-reported Outcome (PRO) Measure and a Clinician-reported Outcome (CRO) Measure to Assess Satisfaction with Pharmacologic Stress Agents for Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI).
    Hudgens S; Spalding J; Chaudhari P
    Clin Ther; 2016 May; 38(5):1141-50. PubMed ID: 26992664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
    Cerqueira MD; Nguyen P; Staehr P; Underwood SR; Iskandrian AE;
    JACC Cardiovasc Imaging; 2008 May; 1(3):307-16. PubMed ID: 19356442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with regadenoson-induced ST-segment depression but normal perfusion on single-photon emission computed tomography.
    Uthamalingam S; Gurm GS; Ahmado I; Sidhu MS; Flynn J
    Angiology; 2013 Jan; 64(1):46-8. PubMed ID: 22323835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the use of pharmacological stress agents during single-photon emission computed tomography myocardial perfusion imaging tests after inadequate exercise stress test.
    Yang H; Faust E; Gao E; Sethi S; Kitt TM; Kristy RM; Spalding JR; Xu Y
    J Nucl Cardiol; 2022 Aug; 29(4):1788-1795. PubMed ID: 33709333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
    Parker MW; Morales DC; Slim HB; Ahlberg AW; Katten DM; Cyr G; Mathur S; Ardestani A; Barmpouletos D; Iyah GS; Borer SM; Heller GV
    J Nucl Cardiol; 2013 Apr; 20(2):185-96. PubMed ID: 23188626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    Iskander F; Iskander M; Gomez J; Doukky R
    J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
    Mahmarian JJ; Peterson LE; Xu J; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Nabi F
    J Nucl Cardiol; 2015 Apr; 22(2):248-61. PubMed ID: 25287737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.
    Johnson NP; Gould KL
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):438-447. PubMed ID: 25797122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
    Brana Q; Thibault F; Courtehoux M; Metrard G; Ribeiro MJ; Angoulvant D; Bailly M
    J Nucl Cardiol; 2022 Feb; 29(1):113-122. PubMed ID: 32651801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
    Hendel RC; Bateman TM; Cerqueira MD; Iskandrian AE; Leppo JA; Blackburn B; Mahmarian JJ
    J Am Coll Cardiol; 2005 Dec; 46(11):2069-75. PubMed ID: 16325044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pharmacologic stress agents: focus on regadenoson.
    Johnson SG; Peters S
    J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.